Panchsheel Organics Ltd. (BSE: 531726) is a Mumbai, Maharashtra-based company in the Medicinal Chemicals and Botanical Products industry. With a market capitalisation of ₹140 Cr, it ranks #2,976 by market cap among the 6,137 Indian listed companies on FinBizNet, and #63 of 86 in Medicinal Chemicals and Botanical Products. At ₹96.90 (as of 25 Oct 2026), the share price is 37.2% below its 52-week high of ₹154.40 and 12.5% above its 52-week low of ₹86.10. The share price is down 28.4% over one year and down 17.8% over three months.
| Current Price | ₹96.90 |
|---|---|
| Market Cap | ₹140 Cr |
| BSE Code | 531726 |
| Sector | Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals |
| Sub-Industry | Biotechnology and Life Sciences > Medicinal Chemicals and Botanical Products |
| P/E Ratio | 12.7 |
| Return on Equity | 7.89% |
| Return on Assets | 4.54% |
| 52-Week Range | ₹86.10 – ₹154.40 |
| 1-Year Price Change | -28.4% |
| 3-Month Price Change | -17.8% |
| Beta (1Y) | 0.54 |
| Dividend Yield | 3.08% |
| Headquarters | Mumbai, Maharashtra |
| Website | www.panchsheelorganics.com |
| Revenue | ₹25 Cr |
|---|---|
| Net Profit | ₹2 Cr |
| Net Margin | 9.4% |
| EPS (Basic) | ₹1.76 |
| Basis | standalone |
Figures in ₹ crore, parsed from the company's exchange filing (XBRL).
Panchsheel Organics Limited engages in the manufacture and trading of bulk drugs and intermediates in India and internationally. It manufactures and exports active pharma ingredients (API), human and veterinary intermediates and finished formulations, specialty chemicals, hormones, steroids, etc. The company also offers a range of products in various categories, such as cardiovascular, neuropsychiatry, anti-fungal, fluoroquinolones, antiallergic, anti-inflammatory, gastrointestinal, osteoporosis, erectile dysfunction, and others. Panchsheel Organics Limited was incorporated in 1989 and is based in Mumbai, India.
1. Bulk Drugs-This segment manufactures and trades in bulk drugs and intermediate products. 2. Formulation-This segment engages in manufacturing and trading of bulk drugs. 3. Manufacturing and Trading of Bulk Drug and Intermediate-This segment engages in marketing of formulation products in India.
1. Manufacturing and Trading of Bulk Drug and Intermediate-100%
| Company | Market Cap | P/E | ROE | Latest Qtr Revenue | 1Y Change |
|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | ₹4,21,995 Cr | 36.4 | 14.72% | ₹15,300 Cr | +5.4% |
| Zydus Lifesciences Ltd | ₹1,12,020 Cr | 22.2 | 18.32% | ₹8,017 Cr | +14.7% |
| Laurus Labs Ltd | ₹1,11,310 Cr | 125.3 | 17.74% | ₹2,026 Cr | +125.7% |
| Cipla Limited | ₹1,07,048 Cr | 27.6 | 11.74% | ₹7,119 Cr | -14.7% |
| Dr.Reddys Lab | ₹1,02,611 Cr | 24.1 | 11.52% | ₹8,698 Cr | -0.9% |
| Aurobindo Pharma Ltd. | ₹95,910 Cr | 26.8 | 9.93% | ₹9,150 Cr | +41.7% |
| Mankind Pharma | ₹93,977 Cr | 48.7 | 12.45% | ₹4,031 Cr | -9.9% |
| Lupin Ltd | ₹89,426 Cr | 16.6 | 26.91% | ₹8,277 Cr | -1.1% |
| Panchsheel Organics Ltd. | ₹140 Cr | 12.7 | 7.89% | ₹25 Cr | -28.4% |
Listed by market capitalisation. Ratios are shown for context only.
Panchsheel Organics Ltd. is trading at ₹96.90, with a market capitalisation of ₹140 Cr.
Panchsheel Organics Ltd. operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Biotechnology and Life Sciences > Medicinal Chemicals and Botanical Products).
Panchsheel Organics Ltd. has a P/E of 12.7 and a return on equity of 7.89%.
Panchsheel Organics Ltd. is listed on the BSE under the scrip code 531726.
Panchsheel Organics Ltd.'s share price is down 28.4% over one year and down 17.8% over three months. Its 52-week range is ₹86.10 to ₹154.40.
In Q1 FY27, Panchsheel Organics Ltd. reported revenue of ₹25 Cr and net profit of ₹2 Cr, with basic EPS of ₹1.76 (standalone, parsed from the company's exchange filing).
Data as of 25 Oct 2026. Descriptive market data only — not investment advice.